The CDC also wanted to include in its FDA authorized labeling that whenever the test generated an inconclusive or positive result, the lab performing the test would be required to send the specimen to the CDC, which would run the sample in its own lab to confirm the finding. But the CDC’s central lab in Atlanta could only handle a few hundred tests a day.
